Skip to main content
Tech.euFundingExplorerBeta

LNC Therapeutics

Gut microbiota drugs development

Total raised
€6.5M
€6,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2017-08
latest 2017-08

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood19
base rate 51% for Series C
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2017-08-25Series C€6.5MSeventure PartnersView deal →

Related news

Similar companies

same sector or country